Keywords: xoma, starts, second, neuprex, efficacy, trial, received

Xoma Starts Second Neuprex Efficacy Trial

Article | 05 June 1995

Print This

Xoma has received US Food and Drug Administration approval to begin its second Phase III efficacy trial of Neuprex (recombinant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in